Position in CHRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$199,305
-$12,115 QoQ
Shares Held
142,361
+13.8% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. CHRS ranks #246 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in CHRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $199,305 | 142,361 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $211,420 | 125,101 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $186,695 | 131,476 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $254,652 | 155,276 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $112,118 | 153,377 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $119,834 | 148,494 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $214,177 | 155,201 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $155,489 | 149,509 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $267,983 | 154,904 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $309,894 | 129,663 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $415,177 | 124,678 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $477,508 | 127,676 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $944,041 | 221,087 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,407,487 | 205,773 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,549,262 | 195,614 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,798,088 | 187,106 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,305,393 | 180,303 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,131,441 | 165,100 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,491,483 | 156,108 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,535,010 | 157,748 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,563,376 | 185,349 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,749,119 | 188,167 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,085,193 | 177,514 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,124,585 | 170,370 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,249,859 | 181,963 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,662,306 | 102,485 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||